We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Selective Exposure in HIV Prevention

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01152281
Recruitment Status : Completed
First Posted : June 29, 2010
Last Update Posted : January 17, 2018
Information provided by (Responsible Party):

Study Description
Brief Summary:

Unfortunately, people most at risk for HIV are the least likely to enroll and remain in prevention programs. In our past work, we have learned how to increase enrollment in such programs among this group. We have identified and addressed previously ignored gender-specific and client self-validation issues that conventional interventions often leave not only uncontrolled, but often biased against participation. The present work will extend these methods from enrollment to retention.

We intend to recruit a sample of 656 at-risk participants through our collaboration with the Duval County, FL Health Department for our randomized, double-blind trial. Our study will investigate if a meta-intervention video designed for empowering participants as agents of their own change can increase the number of attended sessions relative to a control condition without such a video. This trial will also determine if a meta-intervention video addressing various emotional/social and instrumental benefits of an HIV-prevention-counseling intervention can also increase the number of attended sessions. These two factors will be crossed, and their effects on retention will be estimated for different genders and ethnicities. Effects on clients' attention to the return sessions as reported by the counselor will also be explored among participants who return.

We will also conduct mediator analyses for investigating if the meta-intervention has mediating influences on corresponding expectations about the return counseling session. As the inclusion of meta-cognitive measures can alter the efficacy of the intervention, half of the sample will receive measures immediately (0-10 minutes) after exposure to the meta-intervention, before attendance to the next session is registered. The other half will not complete these measures.

Condition or disease Intervention/treatment Phase
HIV Infections Behavioral: Maximal Control Behavioral: Instrumental and Empowering Behavioral: Minimal Control Behavioral: Instrumental Behavioral: Empowering Phase 2

Detailed Description:
  1. After the Informed Consent is signed, the research assistant supervises administration of the baseline questionnaire via ACASI. In ACASI, the questions are seen on the computer screen and heard through earphones simultaneously. This technique has been shown to enhance the accuracy of any reported non-normative behavior by the relative privacy and anonymity it affords. It is expected to take about 30 minutes.
  2. Participants are seen for one-on-one HIV counseling for approximately 20 minutes by counselors briefed to the study according to the protocol described in the attached document "Scripts Florida Study.doc" (hereinafter "the Scripts document").
  3. After the counseling session, participants will watch a 20-minute video delivering one of the experimental or control meta-intervention messages, which are more fully described in the Scripts document.
  4. The self-reporting of expectations and intentions that we need to elicit at this point may have a confounding effect on the retention that the study hopes to measure. Therefore, half of the participants will skip the next step and half will complete it, to allow us to assess the actual effect of this self-report measure on retention while studying if these measures mediate retention.
  5. The half of the participants reporting expectations will report their expectations and intentions for further counseling, via a 10-minute ACASI questionnaire. The questionnaire is designed to distinguish the dimensions of social/emotional, instrumental and empowering expectations.
  6. At the end of the first 70-80 minute session, the counselor schedules the follow-up appointments.
  7. Customary phone reminders are issued two days before each 20-minute follow-up session, as is routine for medical and counseling appointments.
  8. The study counselor does the following at each follow-up session:

    • Records the participant's attendance or absence on the Counselor's Questionnaire.
    • For attending participants, the study counselor rates their attention to the counseling on the Counselor's Questionnaire.
    • The RA in charge of video presentation rates attention to the videos.
    • At the end of the second session, the study counselor double-checks the third appointment with the participant, and reschedules if necessary.
  9. A detailed description of the two follow-up sessions is found in the attached document titled "Counselor Guidelines (2nd and 3rd sessions). The questions and statements therein will be delivered and answered verbally.
  10. At the end of the third session, participants who did not answer the questionnaire in Step 5 will answer a similar questionnaire about their reactions to the meta-intervention video.
  11. All participants will be fully debriefed. Non-attendees will be called and debriefed either by phone or in person based on their preferences.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 722 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Prevention
Official Title: Study to Test Meta-intervention to Increase Retention in HIV Prevention Counseling
Study Start Date : May 2010
Primary Completion Date : April 30, 2017
Study Completion Date : April 30, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Active Comparator: Maximal Control
Basic awareness messages with stories of people living with AIDS
Behavioral: Maximal Control
30 min video with stories of people with HIV. Content describes general health and emotional benefits of counseling.
Experimental: Instrumental
Instrumental messages with stories of people living with HIV
Behavioral: Instrumental
Instrumental messages with stories of people living with HIV
Experimental: Empowering
Empowering messages with stories of people living with HIV
Behavioral: Empowering
Empowering messages with stories of people living with HIV
Experimental: Instrumental and Empowering
Instrumental and empowering messages with stories of people living with HIV
Behavioral: Instrumental and Empowering
Mix of Instrumental and empowering messages with stories of people living with HIV
Active Comparator: Minimal Control
Basic awareness messages with stories of people who are not infected with HIV
Behavioral: Minimal Control
Control messages to increase awareness of HIV risk

Outcome Measures

Primary Outcome Measures :
  1. Enrollment [ Time Frame: 1 month ]
    return rate for 2 upcoming sessions

Secondary Outcome Measures :
  1. Perceptions of the counselor [ Time Frame: 0-10 minutes ]
    Questionnaire measures of perceptions of the counseling session

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Sexually active,
  • Low condom use,
  • Low intention to use condom

Exclusion Criteria:

  • Trying to get pregnant
  • HIV positive
  • with contaminant knowledge about the study
  • planning to leave the area
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01152281

United States, Florida
Duval County Health Department
Jacksonville, Florida, United States, 32211
Sponsors and Collaborators
University of Illinois at Urbana-Champaign
Duval County Health Department
Principal Investigator: Dolores Albarracin, PhD University of Illinois at Urbana-Champaign
More Information

Responsible Party: Dolores Albarracin, PhD, University of Illinois at Urbana-Champaign
ClinicalTrials.gov Identifier: NCT01152281     History of Changes
Other Study ID Numbers: selectiveexposure
First Posted: June 29, 2010    Key Record Dates
Last Update Posted: January 17, 2018
Last Verified: June 2010

Keywords provided by Dolores Albarracin, University of Illinois at Urbana-Champaign:
Basic control
Control with stories of people with AIDS
Instrumental and Empowering

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases